Annual FCF
$28.23 M
+$65.88 M+175.01%
December 31, 2021
Summary
- As of February 10, 2025, LJPC annual free cash flow is $28.23 million, with the most recent change of +$65.88 million (+175.01%) on December 31, 2021.
- During the last 3 years, LJPC annual FCF has risen by +$182.94 million (+118.25%).
Performance
LJPC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
$6.68 M
+$4.16 M+165.05%
June 30, 2022
Summary
- As of February 10, 2025, LJPC quarterly free cash flow is $6.68 million, with the most recent change of +$4.16 million (+165.05%) on June 30, 2022.
- Over the past year, LJPC quarterly FCF has dropped by -$454.00 thousand (-6.36%).
Performance
LJPC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
$13.12 M
-$454.00 K-3.34%
June 30, 2022
Summary
- As of February 10, 2025, LJPC TTM free cash flow is $13.12 million, with the most recent change of -$454.00 thousand (-3.34%) on June 30, 2022.
- Over the past year, LJPC TTM FCF has increased by +$5.86 million (+80.55%).
Performance
LJPC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
LJPC Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +175.0% | -6.4% | +80.5% |
| 3 y3 years | +118.3% | +139.8% | +115.3% |
| 5 y5 years | +129.9% | +132.7% | +115.3% |
LJPC Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -62.3% | -53.5% | at low |
| 5 y | 5-year | at high | -403.3% | -61.1% | -356.7% | -53.5% | -752.6% |
| alltime | all time | at high | -647.9% | -76.8% | -845.5% | -53.5% | -1278.8% |
La Jolla Pharmaceutical Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $6.68 M(+165.1%) | $13.12 M(-3.3%) |
| Mar 2022 | - | $2.52 M(-20.3%) | $13.58 M(-51.9%) |
| Dec 2021 | $28.23 M(-175.0%) | $3.16 M(+318.0%) | $28.23 M(+58.7%) |
| Sep 2021 | - | $757.00 K(-89.4%) | $17.79 M(+144.7%) |
| Jun 2021 | - | $7.14 M(-58.5%) | $7.27 M(-188.5%) |
| Mar 2021 | - | $17.18 M(-335.9%) | -$8.21 M(-78.2%) |
| Dec 2020 | -$37.64 M(-56.1%) | -$7.28 M(-25.4%) | -$37.64 M(-20.8%) |
| Sep 2020 | - | -$9.76 M(+17.0%) | -$47.51 M(-16.1%) |
| Jun 2020 | - | -$8.35 M(-31.9%) | -$56.60 M(-13.0%) |
| Mar 2020 | - | -$12.25 M(-28.6%) | -$65.03 M(-24.1%) |
| Dec 2019 | -$85.65 M(-44.6%) | -$17.15 M(-9.0%) | -$85.65 M(-14.9%) |
| Sep 2019 | - | -$18.86 M(+12.4%) | -$100.62 M(-15.5%) |
| Jun 2019 | - | -$16.77 M(-49.0%) | -$119.05 M(-15.4%) |
| Mar 2019 | - | -$32.87 M(+2.3%) | -$140.73 M(-9.0%) |
| Dec 2018 | -$154.71 M(+64.1%) | -$32.12 M(-13.8%) | -$154.71 M(+1.2%) |
| Sep 2018 | - | -$37.28 M(-3.1%) | -$152.84 M(+12.1%) |
| Jun 2018 | - | -$38.46 M(-17.9%) | -$136.32 M(+15.2%) |
| Mar 2018 | - | -$46.84 M(+54.8%) | -$118.33 M(+25.5%) |
| Dec 2017 | -$94.28 M(+54.7%) | -$30.26 M(+45.8%) | -$94.28 M(+13.0%) |
| Sep 2017 | - | -$20.76 M(+1.5%) | -$83.42 M(+6.7%) |
| Jun 2017 | - | -$20.46 M(-10.2%) | -$78.19 M(+11.3%) |
| Mar 2017 | - | -$22.79 M(+17.4%) | -$70.24 M(+15.3%) |
| Dec 2016 | -$60.93 M(+125.7%) | -$19.41 M(+25.0%) | -$60.93 M(+21.5%) |
| Sep 2016 | - | -$15.52 M(+24.0%) | -$50.13 M(+24.0%) |
| Jun 2016 | - | -$12.51 M(-7.2%) | -$40.43 M(+16.9%) |
| Mar 2016 | - | -$13.48 M(+56.5%) | -$34.58 M(+28.1%) |
| Dec 2015 | -$27.00 M(+105.5%) | -$8.62 M(+48.1%) | -$27.00 M(+12.7%) |
| Sep 2015 | - | -$5.82 M(-12.8%) | -$23.96 M(+14.3%) |
| Jun 2015 | - | -$6.67 M(+13.0%) | -$20.96 M(+28.7%) |
| Mar 2015 | - | -$5.90 M(+5.8%) | -$16.29 M(+24.0%) |
| Dec 2014 | -$13.14 M(+175.0%) | -$5.58 M(+97.7%) | -$13.14 M(+36.4%) |
| Sep 2014 | - | -$2.82 M(+41.2%) | -$9.63 M(+21.1%) |
| Jun 2014 | - | -$2.00 M(-27.2%) | -$7.96 M(+16.7%) |
| Mar 2014 | - | -$2.74 M(+32.4%) | -$6.82 M(+42.7%) |
| Dec 2013 | -$4.78 M(+123.7%) | -$2.07 M(+81.4%) | -$4.78 M(+51.0%) |
| Sep 2013 | - | -$1.14 M(+33.1%) | -$3.16 M(+28.4%) |
| Jun 2013 | - | -$858.00 K(+21.7%) | -$2.46 M(+13.0%) |
| Mar 2013 | - | -$705.00 K(+53.9%) | -$2.18 M(+2.2%) |
| Dec 2012 | -$2.13 M(+16.9%) | -$458.00 K(+3.4%) | -$2.13 M(-0.2%) |
| Sep 2012 | - | -$443.00 K(-23.0%) | -$2.14 M(+7.7%) |
| Jun 2012 | - | -$575.00 K(-12.7%) | -$1.99 M(-6.4%) |
| Mar 2012 | - | -$659.00 K(+42.6%) | -$2.12 M(+16.2%) |
| Dec 2011 | -$1.83 M(-46.2%) | -$462.00 K(+59.3%) | -$1.83 M(+3.2%) |
| Sep 2011 | - | -$290.00 K(-59.2%) | -$1.77 M(-22.3%) |
| Jun 2011 | - | -$710.00 K(+95.1%) | -$2.28 M(-27.1%) |
| Mar 2011 | - | -$364.00 K(-10.3%) | -$3.13 M(-7.8%) |
| Dec 2010 | -$3.39 M(-79.5%) | -$406.00 K(-49.2%) | -$3.39 M(-26.0%) |
| Sep 2010 | - | -$799.00 K(-48.7%) | -$4.58 M(-28.7%) |
| Jun 2010 | - | -$1.56 M(+148.6%) | -$6.42 M(-55.5%) |
| Mar 2010 | - | -$627.00 K(-60.7%) | -$14.45 M(-12.7%) |
| Dec 2009 | -$16.55 M(-69.2%) | -$1.60 M(-39.6%) | -$16.55 M(-43.3%) |
| Sep 2009 | - | -$2.64 M(-72.4%) | -$29.21 M(-28.1%) |
| Jun 2009 | - | -$9.59 M(+250.8%) | -$40.63 M(-6.6%) |
| Mar 2009 | - | -$2.73 M(-80.8%) | -$43.50 M(-19.1%) |
| Dec 2008 | -$53.80 M | -$14.25 M(+1.3%) | -$53.80 M(+5.1%) |
| Sep 2008 | - | -$14.06 M(+12.9%) | -$51.21 M(+513.0%) |
| Jun 2008 | - | -$12.46 M(-4.4%) | -$8.35 M(-81.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$13.03 M(+11.8%) | -$45.72 M(+7.4%) |
| Dec 2007 | -$42.57 M(+44.4%) | -$11.66 M(-140.5%) | -$42.57 M(+11.0%) |
| Sep 2007 | - | $28.79 M(-157.8%) | -$38.34 M(-48.5%) |
| Jun 2007 | - | -$49.82 M(+404.2%) | -$74.50 M(+126.9%) |
| Mar 2007 | - | -$9.88 M(+33.0%) | -$32.83 M(+11.4%) |
| Dec 2006 | -$29.48 M(+7.6%) | -$7.43 M(+0.9%) | -$29.48 M(+7.9%) |
| Sep 2006 | - | -$7.37 M(-9.7%) | -$27.32 M(+7.1%) |
| Jun 2006 | - | -$8.15 M(+24.8%) | -$25.50 M(-1.1%) |
| Mar 2006 | - | -$6.53 M(+24.0%) | -$25.79 M(-5.9%) |
| Dec 2005 | -$27.41 M(-27.5%) | -$5.27 M(-5.0%) | -$27.41 M(-19.4%) |
| Sep 2005 | - | -$5.55 M(-34.3%) | -$34.01 M(-8.7%) |
| Jun 2005 | - | -$8.44 M(+3.5%) | -$37.26 M(-2.3%) |
| Mar 2005 | - | -$8.16 M(-31.2%) | -$38.13 M(+0.8%) |
| Dec 2004 | -$37.81 M(-9.6%) | -$11.86 M(+34.8%) | -$37.81 M(+13.9%) |
| Sep 2004 | - | -$8.80 M(-5.4%) | -$33.20 M(+4.0%) |
| Jun 2004 | - | -$9.31 M(+18.7%) | -$31.92 M(-10.8%) |
| Mar 2004 | - | -$7.84 M(+8.2%) | -$35.80 M(-14.4%) |
| Dec 2003 | -$41.82 M(-3.4%) | -$7.25 M(-3.7%) | -$41.82 M(-12.4%) |
| Sep 2003 | - | -$7.52 M(-42.9%) | -$47.75 M(-5.6%) |
| Jun 2003 | - | -$13.18 M(-4.9%) | -$50.61 M(+4.2%) |
| Mar 2003 | - | -$13.86 M(+5.2%) | -$48.56 M(+12.1%) |
| Dec 2002 | -$43.31 M(+70.8%) | -$13.18 M(+27.0%) | -$43.31 M(+21.3%) |
| Sep 2002 | - | -$10.38 M(-6.7%) | -$35.70 M(+16.6%) |
| Jun 2002 | - | -$11.13 M(+29.2%) | -$30.61 M(+3.2%) |
| Mar 2002 | - | -$8.62 M(+54.6%) | -$29.66 M(+17.0%) |
| Dec 2001 | -$25.36 M(+103.0%) | -$5.57 M(+5.3%) | -$25.36 M(+9.2%) |
| Sep 2001 | - | -$5.29 M(-48.0%) | -$23.21 M(+9.5%) |
| Jun 2001 | - | -$10.18 M(+136.0%) | -$21.19 M(+48.5%) |
| Mar 2001 | - | -$4.31 M(+25.9%) | -$14.27 M(+14.2%) |
| Dec 2000 | -$12.50 M(+5.3%) | -$3.43 M(+4.7%) | -$12.50 M(+3.8%) |
| Sep 2000 | - | -$3.27 M(+0.5%) | -$12.03 M(-1.0%) |
| Jun 2000 | - | -$3.26 M(+28.3%) | -$12.16 M(-1.2%) |
| Mar 2000 | - | -$2.54 M(-14.4%) | -$12.30 M(+3.7%) |
| Dec 1999 | -$11.87 M(+62.5%) | -$2.96 M(-12.8%) | -$11.87 M(+15.2%) |
| Sep 1999 | - | -$3.40 M(0.0%) | -$10.30 M(+21.2%) |
| Jun 1999 | - | -$3.40 M(+61.9%) | -$8.50 M(+18.1%) |
| Mar 1999 | - | -$2.10 M(+50.0%) | -$7.20 M(-1.4%) |
| Dec 1998 | -$7.30 M(+2333.3%) | -$1.40 M(-12.5%) | -$7.30 M(+4.3%) |
| Sep 1998 | - | -$1.60 M(-23.8%) | -$7.00 M(-4.1%) |
| Jun 1998 | - | -$2.10 M(-4.5%) | -$7.30 M(+21.7%) |
| Mar 1998 | - | -$2.20 M(+100.0%) | -$6.00 M(+1900.0%) |
| Dec 1997 | -$300.00 K(-97.5%) | -$1.10 M(-42.1%) | -$300.00 K(-84.2%) |
| Sep 1997 | - | -$1.90 M(+137.5%) | -$1.90 M(-42.4%) |
| Jun 1997 | - | -$800.00 K(-122.9%) | -$3.30 M(-40.0%) |
| Mar 1997 | - | $3.50 M(-229.6%) | -$5.50 M(-54.2%) |
| Dec 1996 | -$12.00 M(+60.0%) | -$2.70 M(-18.2%) | -$12.00 M(-3.2%) |
| Sep 1996 | - | -$3.30 M(+10.0%) | -$12.40 M(+44.2%) |
| Jun 1996 | - | -$3.00 M(0.0%) | -$8.60 M(+6.2%) |
| Mar 1996 | - | -$3.00 M(-3.2%) | -$8.10 M(+8.0%) |
| Dec 1995 | -$7.50 M(-24.2%) | -$3.10 M(-720.0%) | -$7.50 M(+21.0%) |
| Sep 1995 | - | $500.00 K(-120.0%) | -$6.20 M(-29.5%) |
| Jun 1995 | - | -$2.50 M(+4.2%) | -$8.80 M(-2.2%) |
| Mar 1995 | - | -$2.40 M(+33.3%) | -$9.00 M(-9.1%) |
| Dec 1994 | -$9.90 M | -$1.80 M(-14.3%) | -$9.90 M(+22.2%) |
| Sep 1994 | - | -$2.10 M(-22.2%) | -$8.10 M(+35.0%) |
| Jun 1994 | - | -$2.70 M(-18.2%) | -$6.00 M(+81.8%) |
| Mar 1994 | - | -$3.30 M | -$3.30 M |
FAQ
- What is La Jolla Pharmaceutical annual free cash flow?
- What is the all time high annual FCF for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical annual FCF year-on-year change?
- What is La Jolla Pharmaceutical quarterly free cash flow?
- What is the all time high quarterly FCF for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical quarterly FCF year-on-year change?
- What is La Jolla Pharmaceutical TTM free cash flow?
- What is the all time high TTM FCF for La Jolla Pharmaceutical?
- What is La Jolla Pharmaceutical TTM FCF year-on-year change?
What is La Jolla Pharmaceutical annual free cash flow?
The current annual FCF of LJPC is $28.23 M
What is the all time high annual FCF for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high annual free cash flow is $28.23 M
What is La Jolla Pharmaceutical annual FCF year-on-year change?
Over the past year, LJPC annual free cash flow has changed by +$65.88 M (+175.01%)
What is La Jolla Pharmaceutical quarterly free cash flow?
The current quarterly FCF of LJPC is $6.68 M
What is the all time high quarterly FCF for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high quarterly free cash flow is $28.79 M
What is La Jolla Pharmaceutical quarterly FCF year-on-year change?
Over the past year, LJPC quarterly free cash flow has changed by -$454.00 K (-6.36%)
What is La Jolla Pharmaceutical TTM free cash flow?
The current TTM FCF of LJPC is $13.12 M
What is the all time high TTM FCF for La Jolla Pharmaceutical?
La Jolla Pharmaceutical all-time high TTM free cash flow is $28.23 M
What is La Jolla Pharmaceutical TTM FCF year-on-year change?
Over the past year, LJPC TTM free cash flow has changed by +$5.86 M (+80.55%)